IO Biotech Inc (NASDAQ:IOBT) traded at $1.7 at close of the session on Monday, July 14 and made an upward move of 15.65% on its previous day’s price.
Looking at the stock we see that its previous close was $1.47 and the beta (5Y monthly) reads 0.367 with the day’s price range being $1.415 – $1.74. In terms of its 52-week price range, IOBT has a high of $1.73 and a low of $0.66. The company’s stock has gained about 13.33% over that past 30 days.
IO Biotech Inc has a market cap of $111.99 million and is expected to release its quarterly earnings report on 2025-May-14.
On the other hand, looking at the outlook for the IOBT stock, short term indicators assign the stock an average of 100% Buy, while medium term indicators assign it an average of 100% Buy.
Based on estimates by 1 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 0 have rated the IO Biotech Inc (IOBT) stock as a Hold, while 1 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is 19.93% off its SMA20 and 31.10% from its 50-day simple moving average. The RSI (14) is pointing at 68.40 while the volatility over the past week is 9.70% and jumps to 8.50% over the past one month.
Coming back to IO Biotech Inc (NASDAQ:IOBT), we note that the average 3-month trading volume was 158.37K, while that of the preceding 10-day period stands at 0.3 million. Current shares outstanding are 65.88 million.
The insiders hold 26.49% of the company’s shares while institutions hold 21.55%. The data shows that short shares as of 2025-06-13, stood at 0.14 million at a short ratio of 0.66. This represents a 44.00 short interest in shares outstanding on 2025-06-13. Shares short fall in June from the previous month at 0.17 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 36.00% up in year-to-date price movement.
